Search research articles
Contact Us
Filters
Showing results (31-40 of 80) with videos related to
Page
of 8
Sort By:
New York State Journal of Medicine
|
January 1, 1992
Eosinophilic globules resembling Mallory bodies in a renal cell carcinoma
P Unger, G Perino, H Schiff, et al.
Der Internist
|
May 8, 2000
[Pair of siblings of Italian ethnicity with hyperferritinemia and cataract]
M Volkmann, J H Schiff, M Hör, et al.
Annals of the Rheumatic Diseases
|
June 29, 2014
Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase
Michael H Schiff, Johannes von Kempis, Ronald Goldblum, et al.
Resuscitation
|
February 13, 2007
A pregnant woman with acute myocardial infarction due to coronary artery dissection: pre-hospital and in-hospital management
J H Schiff, A Gries, R Ehehalt, et al.
Annals of the Rheumatic Diseases
|
March 5, 2002
Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide
P Emery, F C Breedveld, M Dougados, et al.
The American Journal of Gastroenterology
|
December 22, 2011
Double-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers
Loren Laine, Alan J Kivitz, Alfonso E Bello, et al.
The Journal of Rheumatology
|
August 4, 2004
Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability
Scott W Baumgartner, Roy M Fleischmann, Larry W Moreland, et al.
Arthritis Research & Therapy
|
September 3, 2011
Integrated safety in tocilizumab clinical trials
Michael H Schiff, Joel M Kremer, Angelika Jahreis, et al.
Arthritis and Rheumatism
|
February 12, 2004
Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial
Edward C Keystone, Michael H Schiff, Joel M Kremer, et al.
Arthritis and Rheumatism
|
June 10, 2004
The safety of anakinra in high-risk patients with active rheumatoid arthritis: six-month observations of patients with comorbid conditions
Michael H Schiff, Gino DiVittorio, John Tesser, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 80) with videos related to
Sort By:
Page
of 8
New York State Journal of Medicine
|
January 1, 1992
Eosinophilic globules resembling Mallory bodies in a renal cell carcinoma
P Unger, G Perino, H Schiff, et al.
Der Internist
|
May 8, 2000
[Pair of siblings of Italian ethnicity with hyperferritinemia and cataract]
M Volkmann, J H Schiff, M Hör, et al.
Annals of the Rheumatic Diseases
|
June 29, 2014
Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase
Michael H Schiff, Johannes von Kempis, Ronald Goldblum, et al.
Resuscitation
|
February 13, 2007
A pregnant woman with acute myocardial infarction due to coronary artery dissection: pre-hospital and in-hospital management
J H Schiff, A Gries, R Ehehalt, et al.
Annals of the Rheumatic Diseases
|
March 5, 2002
Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide
P Emery, F C Breedveld, M Dougados, et al.
The American Journal of Gastroenterology
|
December 22, 2011
Double-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers
Loren Laine, Alan J Kivitz, Alfonso E Bello, et al.
The Journal of Rheumatology
|
August 4, 2004
Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability
Scott W Baumgartner, Roy M Fleischmann, Larry W Moreland, et al.
Arthritis Research & Therapy
|
September 3, 2011
Integrated safety in tocilizumab clinical trials
Michael H Schiff, Joel M Kremer, Angelika Jahreis, et al.
Arthritis and Rheumatism
|
February 12, 2004
Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial
Edward C Keystone, Michael H Schiff, Joel M Kremer, et al.
Arthritis and Rheumatism
|
June 10, 2004
The safety of anakinra in high-risk patients with active rheumatoid arthritis: six-month observations of patients with comorbid conditions
Michael H Schiff, Gino DiVittorio, John Tesser, et al.
Page
of 8